Drobnjak Tijana, Gizurarson Sveinbjörn, Gokina Natalia I, Meiri Hamutal, Mandalá Maurizio, Huppertz Berthold, Osol George
a Faculty of Pharmaceutical Sciences , School of Health Science, University of Iceland , Reykjavik , Iceland.
b Department of Obstetrics , Gynecology and Reproductive Sciences, University of Vermont , Burlington , Vermont , USA.
Hypertens Pregnancy. 2017 May;36(2):186-195. doi: 10.1080/10641955.2017.1295052. Epub 2017 May 19.
Placental protein 13 (PP13) induces hypotension in rats. This study aims to evaluate PP13 effects on isolated uterine arteries from nonpregnant and mid-pregnant rats. Vessels were isolated, cannulated, and pressurized to 50 mmHg within an arteriograph, preconstricted and exposed to increasing PP13 concentrations (10-10 M). PP13 elicited 38-50% arterial vasodilation with half-maximum response (EC) = 1 pM. The relaxation was mediated by activating the endothelial-signaling pathways of prostaglandin and nitric oxide (NO). Accordingly, these results encourage evaluation of PP13 as a possible therapy for gestational diseases characterized by insufficient uteroplacental blood flow and/or maternal hypertension.
胎盘蛋白13(PP13)可诱导大鼠出现低血压。本研究旨在评估PP13对未孕和孕中期大鼠离体子宫动脉的影响。分离血管,插管后在血管造影仪中加压至50 mmHg,预先收缩后再暴露于递增的PP13浓度(10-10 M)下。PP13可引起38%-50%的动脉血管舒张,半数最大效应浓度(EC)= 1 pM。这种舒张是通过激活前列腺素和一氧化氮(NO)的内皮信号通路介导的。因此,这些结果促使人们评估PP13作为一种可能的治疗方法,用于治疗以子宫胎盘血流不足和/或母体高血压为特征的妊娠疾病。